Found: 4
Select item for more details and to access through your institution.
Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
- Published in:
- 2010
- By:
- Publication type:
- Other
Cidofovir induces an increase in levels of low-risk and high-risk HPV E6.
- Published in:
- Head & Neck, 2009, v. 31, n. 7, p. 893, doi. 10.1002/hed.21043
- By:
- Publication type:
- Article
Effects of cidofovir on a novel cell-based test system for recurrent respiratory papillomatosis.
- Published in:
- Head & Neck, 2007, v. 29, n. 8, p. 741, doi. 10.1002/hed.20572
- By:
- Publication type:
- Article
Age at diagnosis, but not HPV type, is strongly associated with clinical course in recurrent respiratory papillomatosis.
- Published in:
- PLoS ONE, 2019, v. 14, n. 6, p. 1, doi. 10.1371/journal.pone.0216697
- By:
- Publication type:
- Article